Overview
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
Status:
Recruiting
Recruiting
Trial end date:
2022-04-01
2022-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This will be a prospective assessment of whether adjuvant Netarsudil use in patients undergoing Descemetorhexis without endothelial keratoplasty improves time to corneal clearance and post-operative central endothelial cell counts. The anticipated enrollment is 25 patients.Phase:
Early Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Criteria
Inclusion Criteria:- Fuchs corneal dystrophy
Exclusion Criteria:
- Women of childbearing potential
- Other corneal eye diseases
- Non-compliance with netarsudil
- Intolerance of netarsudil